-
-
-
-
-
-
-
Abivax (ABVX) Reiterated at Market Outperform by Citizens on Open-label Results
-
-
-
-
-
-
-
Abivax (ABVX) PT Raised to $114 at Citizens JMP
-
-
-
-
-
-
-
Abivax Presents Impressive New Phase 2a ABX464 Ulcerative Colitis 6-Months Maintenance Study Data in Oral Plenary Session at Annual Congress of European Crohn’s and Colitis Organisation (ECCO)
-
-
-
-
-
-
-
ABIVAX: 2015 Full-Year Results and Progress Report
-
1,231,020 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


